FACULTY
Francesca Morgante, MD, PhD - St. George's University of London, London, United Kingdom
LEARNING OBJECTIVES
Upon completion of this activity learners will be able to:
1. Demonstrate an understanding of the mechanism of action for the available intestinal infusions used in the treatment of Parkinson’s disease.
2. Apply the latest information to identify the appropriate patients with Parkinson’s disease for levodopa/carbidopa and levodopa/carbidopa/entacapone intestinal infusions.
3. Familiarize yourself with the potential adverse effects of the available intestinal infusions.
ABOUT THE ESSENTIALS OF DEVICE-ASSISTED THERAPIES IN PARKINSON'S DISEASE SERIES
The MDS Essentials of Device Assisted Therapies in Parkinson's Disease Series is an online education program designed to focus on the main practical issues involved in therapeutic treatments of Parkinson's Disease.
INTENDED AUDIENCE
This course is intended for students, residents, neurologists, neurosurgeons, specialist nurses, and other health professionals.
HOW TO TRANSLATE THIS MODULE
For step-by-step guidance on how to translate this module using the Google Chrome web browser, please watch the video below:
HARDWARE AND SOFTWARE REQUIREMENTS
1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Mozilla Firefox or Google Chrome.
4. Adobe Flash Player 12.0 (or higher).
5. Adobe Reader to print certificate.